Independent vendors are on the rise providing superior solutions for each individual aspect of this eco-system, from medical devices to data management tools. An unfortunate consequence of this multi-vendor environment is a massive fragmentation of data and a pandemic “silo’ing” of vital information. To liberate the data trapped in various silos to accelerate clinical trials, New Jersey-based Adaptive Clinical Systems built from the ground up the Adaptive eClinical Bus® as the first true interoperability platform. “It is a cloud-based iPaaS, specifically engineered to work with the most popular eClinical systems,” explains Sina Adibi, president and CEO of Adaptive Clinical Systems.
Adaptive Clinical Systems: Liberating Data from Silos to Accelerate Clinical Trials
In conjunction with its integral Adaptive Rules Engine, the eClinicalBus allows for the real-time exchange of data across disparate systems from different eClinical vendors. The modular architecture enables a rapid, user-friendly setup. Its high level of component reuse helps COOs to codify operational processes and to utilize them again as canned procedures leveraging the eClinical Bus’ drag-and-drop interface.
With a flexible iPaaS architecture, a client’s clinical know-how is modified in the context of each individual drug development cycle. Once the company, as part of its services, establishes the workflow and data transfer rules through the eClinical Bus, Adaptive Clinical’s knowledgeable staff performs all necessary compliance related testing and certification. After the changes have been applied, the entire Adaptive eClinical Bus framework is recertified on an ongoing basis, which is an added advantage for CIOs.
As there can be uncertainties during the drug development lifecycle, the pay-as-you-go business model allows for a predictable cost structure for CFOs that want to utilize the Adaptive eClinical Bus. Clients need not be concerned about a significant capital investment upfront.
“In the coming months, we are finalizing our 2019 go-to-market strategy leveraging new channels and addressing the pain points and needs of our constituency,” says Adibi. As the established vendor of record for attaining true interoperability, the company will expand its partners’ portfolio through establishing strategic relationships with new and emerging EHRs/ EMRs, eClinical vendors, as well as manufacturers of medical devices and medical monitoring wearables. Adaptive Clinical will continue to participate and work closely with industry-wide consortia and regulatory task forces to promote and establish interoperability as a requirement for drug discovery.